Pathstone Family Office’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $298K | Buy |
+832
| New | +$298K | ﹤0.01% | 1308 |
|
|
2023
Q2 | – | Sell |
-483
| Closed | -$275K | – | 1241 |
|
|
2023
Q1 | $275K | Sell |
483
-894
| -65% | -$509K | ﹤0.01% | 952 |
|
|
2022
Q4 | $573K | Buy |
1,377
+118
| +9% | +$49.1K | ﹤0.01% | 1040 |
|
|
2022
Q3 | $525K | Buy |
+1,259
| New | +$525K | ﹤0.01% | 1057 |
|
|
2021
Q1 | – | Sell |
-24
| Closed | -$14K | – | 717 |
|
|
2020
Q4 | $14K | Buy |
+24
| New | +$14K | ﹤0.01% | 788 |
|